HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Muscle-derived autologous mitochondrial transplantation: A novel strategy for treating cerebral ischemic injury.

Abstract
The available evidence showed that mitochondrial transfer by releasing the extracellular vesicles containing mitochondria from astrocytes to neurons exerted a neuroprotective effect after stroke. Whether extracellular mitochondrial replenishment could rescue the tissues from cerebral ischemic injury still needs to be explored completely. It was hypothesized that the augmentation of mitochondrial damage after cerebral ischemia could be resolved by timely replenishment of exogenous mitochondria. A stroke model of middle cerebral artery occlusion (MCAO) was used in this study to verify this hypothesis. This study found that the number of extracellular mitochondria increased in rat cerebrospinal fluid after MCAO, and a higher proportion of mitochondria were associated with good neurological outcomes. Following 90-min ischemia, autologously derived mitochondria (isolated from autologous pectoralis major) or vehicle alone was infused directly into the lateral ventricles, and the rats were allowed to recover for 4 weeks. A plenty of infused mitochondria were found to be distributed in the boundary and ischemic penumbra areas. Furthermore, the transplantation of mitochondria reduced cellular oxidative stress and apoptosis, attenuated reactive astrogliosis, and promoted neurogenesis after stroke. Moreover, the transplantation of mitochondria decreased brain infarct volume and reversed neurological deficits. The findings suggested that the delivery of mitochondria through the lateral ventricles resulted in their widespread distribution throughout the brain and exerted a neuroprotective effect after ischemia-reperfusion injury.
AuthorsZhanqin Zhang, Zhi Ma, Chaoying Yan, Kairui Pu, Meiyan Wu, Juan Bai, Yansong Li, Qiang Wang
JournalBehavioural brain research (Behav Brain Res) Vol. 356 Pg. 322-331 (01 01 2019) ISSN: 1872-7549 [Electronic] Netherlands
PMID30213662 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Elsevier B.V. All rights reserved.
Chemical References
  • Neuroprotective Agents
  • Reactive Oxygen Species
Topics
  • Animals
  • Apoptosis (drug effects)
  • Brain (drug effects)
  • Brain Ischemia (drug therapy, metabolism)
  • Disease Models, Animal
  • Infarction, Middle Cerebral Artery (drug therapy, metabolism)
  • Male
  • Membrane Potential, Mitochondrial (drug effects)
  • Mitochondria (metabolism, transplantation)
  • Neurons (drug effects, metabolism)
  • Neuroprotective Agents (pharmacology)
  • Oxidative Stress (drug effects)
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species (metabolism)
  • Reperfusion Injury (drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: